Sa A Wang

Sa A Wang is a Professor in the Department of Hematopathology at The University of Texas MD Anderson Cancer Center. Her research focuses on the pathology of acute myeloid leukemia, mixed-phenotype acute leukemia, mast cell leukemia, and lymphoid neoplasia, with particular emphasis on the genomic landscape of BCL11B-rearranged leukemias, measurable residual disease (MRD) detection by flow cytometry, and clonal dynamics post-HSCT. Her recent work has appeared in Blood, Modern Pathology, and Blood Advances, including ELN-DAVID consensus guidelines for MRD assessment. Widely recognized as a senior leader in hematopathology, she contributes extensively to international diagnostic standardization efforts, particularly through the BCR::ABL1 Pathology Group and ELN-DAVID collaboration.